Article thumbnail
Location of Repository

PCN46 Budget Impact Analysis of the Introduction of New Therapeutic Agents for the Treatment of Metastatic Castration Resistant Prostate Cancer (MCRPC) Patients After Docetaxel Failure in the Brazilian Private Health System

By E. Asano and V. Vitale
Publisher: Published by Elsevier Inc.
Year: 2014
DOI identifier: 10.1016/j.jval.2014.08.2204
OAI identifier:

Suggested articles


To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.